Purva Bali
- Molecular Biology top 2%
- Hematology top 1%
- Oncology top 5%
- Cancer Research top 5%
- Cellular and Molecular Neuroscience top 5%
- Co-authors
- Kapil N. BhallaFei GuoPeter AtadjaPaul J. KennyWarren FiskusHeh‐In ImJonathan A. HollanderMaria E. Balasis
- Topics
- Histone Deacetylase Inhibitors Research (13 papers)Chronic Myeloid Leukemia Treatments (8 papers)Chronic Lymphocytic Leukemia Research (6 papers)
- Partner nations
- United StatesSwitzerlandIndia
In The Last Decade
Purva Bali
39 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 3.1k
- Hematology 682
- Oncology 665
- Cancer Research 483
- Cellular and Molecular Neuroscience 339
Countries citing papers authored by Purva Bali
This map shows the geographic impact of Purva Bali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purva Bali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purva Bali more than expected).
Fields of papers citing papers by Purva Bali
This network shows the impact of papers produced by Purva Bali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purva Bali. The network helps show where Purva Bali may publish in the future.
Co-authorship network of co-authors of Purva Bali
This figure shows the co-authorship network connecting the top 25 collaborators of Purva Bali. A scholar is included among the top collaborators of Purva Bali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purva Bali. Purva Bali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 20 | |
| 3 | 21 | |
| 4 | 53 | |
| 5 | 20 | |
| 6 | 29 | |
| 7 | 322 | |
| 8 | 356 | |
| 9 | 81 | |
| 10 | 156 | |
| 11 | 2 | |
| 12 | Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90breakdown → | 644 |
| 13 | 1 | |
| 14 | 76 | |
| 15 | 1 | |
| 16 | 114 | |
| 17 | 28 | |
| 18 | Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B. | 228 |
| 19 | 136 | |
| 20 | 21 |
About Purva Bali
Purva Bali is a scholar working on Hematology, Genetics and Developmental Neuroscience, having authored 41 papers that have together received 3.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (13 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Hematology (682 citations), Molecular Biology (3.1k citations) and Cancer Research (483 citations). Purva Bali has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Kapil N. Bhalla, Fei Guo, Peter Atadja, Paul J. Kenny, Warren Fiskus, Heh‐In Im, Jonathan A. Hollander, Maria E. Balasis, Kathy Rocha and Michael Pranpat. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.